Sleep and circadian interventions for college students at high risk of suicide
Official title: Triple Chronotherapy + Transdiagnostic Sleep and Circadian Intervention (TSC+) for Suicidal Young Adults
Run by University of Pittsburgh · NCT07346014 · Data updated 2026-11-12
Three sleep-focused approaches are being tested to see if they can help reduce suicidal thoughts and depression in high-risk college students receiving psychiatric care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 25 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | University of Pittsburgh Academic / other |
| Locations | 1 site (Pittsburgh, Pennsylvania) |
| Status | Recruiting |
| Started | June 18, 2026 |
| Main results expected | March 2029 |
| Study ends | March 2029 |
| Registry record updated | July 7, 2026 |
| Trial ID | NCT07346014 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are college students enrolled in COSTAR Intensive Outpatient Program with recent suicidal ideation or attempt and clinically significant sleep disturbance.
✕Probably not a fit
Students without sleep disturbance or those not receiving psychiatric care may be less likely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study randomizes acutely suicidal college students in intensive outpatient treatment to one of three sleep-based interventions. Participants receive either Triple Chronotherapy plus a transdiagnostic sleep and circadian intervention, the transdiagnostic sleep and circadian intervention alone, or a Sleep Feedback with psychoeducation. The study follows participants for six months, with blinded clinicians assessing suicidal thoughts, behaviors, and depression at early, mid, and long-term time points. The goal is to determine whether adding sleep-focused treatment improves short- and longer-term suicide risk reduction beyond standard care.
Why it matters
Potential benefit: If successful, the interventions could offer faster or more sustained reduction in suicidality and depressive symptoms for high-risk college students.
How similar studies have gone: Previous open studies suggest rapid mood improvements with Triple Chronotherapy, but suicide-focused trials are not yet established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Enrolled or planning to enroll in treatment at COSTAR Intensive Outpatient Program * English language fluency and literacy sufficient to engage in study protocol * Suicidal ideation or suicide attempt in past month * Clinically significant sleep disturbance, operationalized as Pittsburgh Sleep Quality Index global PSQI score \>= 7, and/or delayed bedtimes (\>midnight), and/or \>2 hours in sleep timing variability Exclusion Criteria: * Non-affective psychosis per electronic health record (EHR) review and/or baseline clinical assessment, or symptom severity or psychosocial functioning impairments that preclude participation * Contraindications for either sleep deprivation or bright light therapy (e.g., bipolar disorder; seizure disorder; photosensitizing medication) * Intellectual disability precluding comprehension of study procedures * Evidence of untreated obstructive sleep apnea and/or restless legs syndrome * Life-threatening medical condition requiring immediate treatment (such as cancer; end stage disease) * Pregnancy
Where it's running
-
Western Psychiatric Hospital/University of Pittsburgh
Pittsburgh, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Tina Goldstein, PhD — University of Pittsburgh
- Study coordinator: Dawn Rice, MS
- Email: ricedm@upmc.edu
- Phone: 412-297-1947
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sleep and bright-light program for teens with depression and sleep problems
This project will try a sleep-and-bright-light program to improve sleep and mood in teens aged 12–18 with moderate-to-severe depression and clinically significant sleep problems who are at risk for suicidal thoughts.
-
Virtual Reality-Based Hypnotherapy to Help Pain, Sleep, and Mood in Spinal Cord Injury
Adults with spinal cord injury will try adding short VR-based hypnotherapy sessions to their standard physiotherapy to see if it reduces pain and improves sleep and mood.
-
Testing a new drug for treatment-resistant depression
This study is testing a new drug called HNK to see if it can help people with treatment-resistant depression feel better when other medications haven't worked.
-
Online cognitive behavioral therapy for preventing suicide and treating depression
This study is testing two online therapy courses for veterans to see if they can help with depression and suicidal thoughts.
-
Using ketamine to help suicidal patients in the emergency department
This study is testing if a low dose of ketamine can safely help people in the emergency department who are feeling suicidal by reducing their symptoms and possibly shortening their hospital stay.
-
Examining brain connectivity in suicidal opioid users
This study is trying to see if a brain stimulation treatment can help reduce cravings and suicidal thoughts in people who use opioids.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.